AT-Patch (ATP-C130/ATP-C70) vs QIR Suite

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AT-Patch (ATP-C130/ATP-C70)

by ATsens Co.

QIR Suite

by CASIS Cardiac Simulation & Imaging Software

AI Verdict

Tool A is an ambulatory ECG monitor with AI for continuous cardiac rhythm monitoring and arrhythmia detection. Tool B is an AI-powered software for quantitative analysis of cardiovascular MR and CT images to support diagnosis and prognosis. While both serve cardiology, they address different diagnostic needs: Tool A focuses on electrophysiology and rhythm disorders through long-term monitoring, whereas Tool B provides detailed structural and functional insights from medical imaging.

Choose AT-Patch (ATP-C130/ATP-C70) if…

Choose AT-Patch if you require extended, continuous monitoring of a patient's cardiac rhythm in an ambulatory setting. This tool is ideal for detecting intermittent arrhythmias or evaluating treatment effectiveness over several days, providing high-accuracy ECG data with minimal patient disruption.

View AT-Patch (ATP-C130/ATP-C70) →

Choose QIR Suite if…

Choose QIR Suite if your primary need is advanced, quantitative analysis of cardiovascular MR and CT images. This software is best suited for cardiologists and radiologists seeking detailed insights into cardiac structure, function, blood flow, and pathological volumes to aid in the diagnosis and prognosis of complex cardiovascular diseases.

View QIR Suite →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AT-Patch (ATP-C130/ATP-C70)	QIR Suite
Pricing	N/a	Contact for pricing
Deployment	Wearable device for patients; analysis software deployed on-premise at medical institutions.	Locally on dedicated hardware
FDA Status	Cleared AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AT-Patch (ATP-C130/ATP-C70)

AT-Patch (Tool A) prioritizes patient comfort and ease of use for continuous monitoring with its compact, lightweight, shower-proof design, and no need for charging or electrode replacement during the monitoring period. It also includes a smartphone app for patient interaction. While QIR Suite (Tool B) aims for efficiency for clinicians through automation, AT-Patch's features directly address the broader usability challenge of long-term patient adherence to a wearable device.

Clinical Value

Tie

Both tools offer significant clinical value in their respective domains and are FDA-cleared. AT-Patch (Tool A) provides crucial continuous ECG data for enhanced arrhythmia detection over extended periods. QIR Suite (Tool B) offers advanced, quantitative AI-based analysis of MR and CT images for detailed diagnosis and prognosis of cardiovascular conditions. Their contributions are distinct and complementary within cardiology, making it difficult to declare one superior in overall clinical value.

Pricing & Value

Tie

Neither tool provides publicly available pricing information. AT-Patch (Tool A) states pricing is 'n/a' and involves direct sales, while QIR Suite (Tool B) requires contacting for pricing and mentions a one-time license or subscription model. Without specific pricing details, a meaningful comparison of their value propositions is not possible.

Enterprise Readiness

AT-Patch (ATP-C130/ATP-C70)

Both tools are designed for on-premise deployment within medical institutions. However, AT-Patch (Tool A) explicitly states it is 'likely' HIPAA compliant given its FDA clearance and operation within the US healthcare system for patient data. QIR Suite (Tool B) has 'not specified' HIPAA compliance, giving Tool A a slight edge in demonstrating readiness for enterprise-level data privacy requirements.

Innovation

Tie

Both tools demonstrate significant innovation in their respective areas. AT-Patch (Tool A) innovates by combining long-term, high-accuracy, and patient-friendly wearable ECG monitoring with integrated AI for arrhythmia analysis. QIR Suite (Tool B) innovates in providing deep, quantitative AI-powered analysis of complex cardiovascular imaging, automating the extraction of over 100 clinical parameters from MR and CT scans. They represent distinct yet equally impactful advancements in cardiovascular care.

Support & Docs

Tie

There is insufficient information available for either AT-Patch (Tool A) or QIR Suite (Tool B) regarding their specific support channels, service level agreements, or public documentation. Neither the provided facts nor general web searches yielded enough detail to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AT-Patch (ATP-C130/ATP-C70)	QIR Suite
Name	AT-Patch (ATP-C130/ATP-C70)	QIR Suite
Primary Function	Wearable ECG monitor for continuous cardiac monitoring and arrhythmia detection.	AI-based medical imaging analysis software for cardiovascular conditions.
Input Data Type	ECG signals	MR and CT images
Key AI/Analysis Capabilities	AI/machine learning algorithms for ECG analysis, enhanced arrhythmia detection.	AI-based analysis of MR and CT examinations, detection of heart regions and pathological areas, quantification of over 100 clinical parameters, automatic segmentation, blood flow/velocities quantification, pathological volumes detection and quantification, semi-quantification of myocardial perfusion, strain quantification.
Monitoring/Analysis Duration	Up to 14 days of continuous ECG monitoring (ATP-C130)	Not specified

Videos

Demos, reviews, and walkthroughs featuring AT-Patch (ATP-C130/ATP-C70) and QIR Suite.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary difference in the type of cardiac data each tool analyzes?

AT-Patch (ATP-C130/ATP-C70) is a wearable ECG monitor that captures and analyzes continuous electrocardiogram signals for up to 14 days. QIR Suite is an AI-based software that analyzes cardiovascular conditions from MR and CT medical images.

How do these tools integrate into a clinical workflow differently?

AT-Patch involves a patient wearing a compact, lightweight device for continuous monitoring, with analysis software deployed on-premise at medical institutions. QIR Suite is software deployed locally on dedicated hardware, used by clinicians to analyze existing MR and CT imaging data.

What specific clinical problems are these tools designed to address?

AT-Patch is designed for continuous cardiac monitoring and enhanced arrhythmia detection. QIR Suite supports the diagnosis and prognosis of cardiovascular conditions through quantitative evaluation of MR and CT images.

Do both tools utilize AI, and if so, in what capacity?

Yes, both tools utilize AI. AT-Patch incorporates AI/machine learning algorithms within its AT-Report software for ECG analysis. QIR Suite uses AI for the analysis of MR and CT examinations, including detection of heart regions, pathological areas, and quantification of clinical parameters.

What are the key differences in patient interaction and comfort for these tools?

AT-Patch is a compact, lightweight (13g), and shower-proof wearable device worn by the patient for up to 14 days, with an optional smartphone app for live ECG viewing and symptom recording. QIR Suite is medical imaging analysis software and does not involve direct patient interaction beyond the initial imaging procedure.

What are the data security and compliance considerations for each tool?

AT-Patch is likely HIPAA compliant given its FDA clearance and operation within the US healthcare system for patient data, though a Business Associate Agreement (BAA) is not explicitly mentioned. For QIR Suite, HIPAA compliance and BAA status are not specified in the provided information.